NB527578
C4.4A/LYPD3 Antibody (lupartumab) [Janelia Fluor™ 585], Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB527578-Each-of-1 | In Stock | ₹ 33,747.02 |
NB527578 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 33,747.02
GST (18%): ₹ 6,074.464
Total Price: ₹ 39,821.484
Antigen
C4.4A/LYPD3
Classification
Monoclonal
Conjugate
Janelia Fluor 585
Gene Alias
C4.4A2310061G07Rik, GPI-anchored metastasis-associated protein C4.4A homolog, GPI-anchored metastasis-associated protein homolog, LY6/PLAUR domain containing 3, ly6/PLAUR domain-containing protein 3, Matrigel-induced gene C4 protein, MIG-C4
Immunogen
LYPD3/ C4.4A
Quantity
0.1 mL
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Applications
Flow Cytometry, ELISA, Functional Assay
Clone
lupartumab
Formulation
50mM Sodium Borate
Host Species
Human
Purification Method
Protein A purified
Regulatory Status
RUO
Gene ID (Entrez)
27076
Content And Storage
Store at 4°C in the dark.
Isotype
IgG1
Related Products
Description
- C4.4A/LYPD3 Monoclonal antibody specifically detects C4.4A/LYPD3 in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay